SWIFT v. PANDEY

CourtDistrict Court, D. New Jersey
DecidedNovember 28, 2023
Docket2:13-cv-00650
StatusUnknown

This text of SWIFT v. PANDEY (SWIFT v. PANDEY) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SWIFT v. PANDEY, (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

ROBERT SWIFT, Plaintiff, Case No. 2:13-cv-00650 (BRM) (JSA) v. OPINION RAMESH PANDEY, et al., Defendants. MARTINOTTI, DISTRICT JUDGE Before the Court is pro se Plaintiff Robert Swift’s (“Plaintiff”) unopposed motion to enforce the settlement agreement between Plaintiff and Defendants Ramesh Pandey and Bhuwan Pandey (the “Pandey Defendants”) related to Defendant Xechem (India) Pvt, Ltd. (“Xechem India”). (ECF No. 507.) Having reviewed Plaintiff’s submission and having declined to hold oral argument pursuant to Federal Rule of Civil Procedure 78(b), for the reasons set forth below and for good cause having been shown, Plaintiff’s Motion to Enforce Settlement (ECF No. 507) is GRANTED. I. BACKGROUND The Court has set forth, at length, the factual and procedural background as it pertains to this action in its Opinions dated August 10, 2016, March 27, 2017, August 31, 2017, October 12, 2017, May 22, 2018, and May 2, 2022. (ECF Nos. 165, 197, 222, 229, 264, 444). The Court hereby incorporates same herein and sets forth only the relevant factual and procedural background as it relates to Plaintiff’s Motion to Enforce Settlement. A. Settlement Agreement Between Plaintiff and the Pandey Defendants A bench trial took place before the Court from August 9, 2022 through August 12, 2022. (See ECF Nos. 473, 474, 475, 476, 496, 497, 498, 499.) During trial, the Court engaged in settlement discussions with Plaintiff and the Pandey Defendants at which time they came to a partial resolution, an oral settlement agreement, regarding Xechem India. (See ECF No. 497 (Trial

Tr. Vol. II) at 22021, 22930; ECF No. 498 (Trial Tr. Vol. III) at 28384; ECF No. 499 (Trial Tr. Vol. IV) at 291; ECF No. 500 (10/05/2022 Hr’g Tr.) at 25.) The Pandey Defendants, both individually and through counsel, represented: (1) they would be willing to transfer to Plaintiff any and all rights and interests they have, and any assets that may exist, in Xechem India; and (2) they would assist in cooperating with Plaintiff to help efficiently facilitate this transfer, including revitalizing or reestablishing Xechem India as a corporation in India, provided this process would be at no cost to the Pandey Defendants and provided Plaintiff would give the Pandey Defendants any paperwork necessary for this process. (See ECF No. 497 at 22021, 22930; ECF No. 498 at

28384; ECF No. 499 at 291; ECF No. 500 at 25.) This oral settlement agreement was memorialized on the record during trial: THE COURT: We are back on the record. Just for purposes of the record I’d like to indicate what has transpired. With permission of counsel and [Plaintiff] Dr. Swift, I spoke with each separately in an effort to resolve the matter. There is a partial resolution regarding the India corporation [Xechem India]. And as I understand it, the [Pandey Defendants] will turn over all their rights and assets that they have in that corporation to Dr. Swift, but will cooperate, provided it is at no cost to them, to help Dr. Swift revitalize or reestablish the corporation in India. And I’m adding this in, but I assume it’s not going to be an issue, will do so efficiently. In other words, counsel, if Dr. Swift sends an e-mail, they are not going to sit on it for three days. They’re going to move it as efficiently and effectively as possible. Is that fair? MR. MARKIN [counsel for the Pandey Defendants]: Yes. THE COURT: Is that fair, Dr. Swift? MR. SWIFT: Yes. Will the Court maintain any jurisdiction to enforce this? THE COURT: I’ll retain jurisdiction to enforce cooperation. MR. SWIFT: Thank you, Your Honor. THE COURT: And Dr. and Colonel Pandey, you are okay with that as far as signing over any and all rights that you have in India and cooperating with Dr. Swift? Colonel Pandey, yes? MR. R. PANDEY: Yes. MR. B. PANDEY: Yes, Your Honor. MR. MARKIN: Just to clarify, whatever Swift needs done is going to come from him. He’s going to give it to us and say, Hey, I need – THE COURT: Right. MR. MARKIN: We’re not going to put anything together. MR. SWIFT: Gene, I have to do it all. THE COURT: But, counsel, you are going to assist for this component? MR. MARKIN: Yes.

(ECF No. 497 at 22930; see also ECF No. 498 at 28384 (“THE COURT: . . . In the meantime, irrespective of this component, it’s clear that Dr. Swift is going to get all the rights of India and your clients are going to cooperate and work with him to facilitate that transfer. Is that correct, Mr. Markin? MR. MARKIN: That’s correct, as long as it doesn’t cost them money or involve any hardship, that’s fine. . . . If he sends us the paperwork for them to sign, they’ll sign it. THE COURT: Is that okay, Dr. Swift? MR. SWIFT: Yes. THE COURT: And I’ll retain jurisdiction over that issue if there’s any issues. And I’ll ask that they cooperate expeditiously as best they can, just to move it forward for the doctor. MR. MARKIN: Sure, Your Honor.”); ECF No. 499 at 291 (“This matter was tried without a jury on August 9 and 10. On August 10, with permission of both parties, the Court engaged in settlement discussions, at which time the parties came to an agreement that the [Pandey Defendants] would transfer any and all [of] their rights and title in Xechem India, hereinafter referred to as India, to [Plaintiff] and cooperate with him to facilitate the transfer.”).) At the close of Plaintiff’s case-in-chief, the Court granted the Pandey Defendants’ motion to dismiss all of Plaintiff’s remaining claims pursuant to Federal Rule of Civil Procedure 52(c). (See ECF No. 499 at 292301.) After a careful review of the record, the testimony, and the evidence, the Court made and provided its findings of fact and conclusions of law on the record on August 12, 2022. (See id.) The Court found Plaintiff did not prove the elements of his remaining claims for unjust enrichment or quantum meruit against either the Pandey Defendants or Xechem India. (See id.) Accordingly, on August 17, 2022, the Court entered final judgment in favor of the Pandey Defendants and against Plaintiff on all claims.1 (ECF No. 481 (“Final Judgment”).)

However, the Court explicitly retained jurisdiction over the settlement agreement between Plaintiff and the Pandey Defendants related to Xechem India for the purpose of enforcing that agreement. (See ECF No. 497 at 22930; ECF No. 498 at 28384; ECF No. 500 at 5.) B. Plaintiff’s Post-Trial Request for an Amended Final Judgment On September 12, 2022, Plaintiff filed a letter with the Court requesting an order and judgment regarding (1) a default judgment against Xechem India2 and (2) the Pandey Defendants’ agreement to “transfer 100% of Xechem (India) Pvt., Ltd. to Plaintiff,” and the Court’s retention of jurisdiction to enforce this agreement between the parties. (ECF No. 482.) The Court construed Plaintiff’s letter as a request to amend the Final Judgment to reflect, inter alia, the Court’s retention

of jurisdiction to enforce the settlement agreement between Plaintiff and the Pandey Defendants to facilitate the transfer of Xechem India to Plaintiff. (See ECF No. 486 at 12.) The next day, on September 13, 2022, Plaintiff filed with the United States Court of Appeals for the Third Circuit (the “Third Circuit”) a Notice of Appeal from the Final Judgment. (ECF No. 483.) Thereafter, the Court issued an order noting it lacked the authority to grant

1 Xechem India was not explicitly mentioned in the Final Judgment, but the Final Judgment reflected it was “a final judgment as to all claims by any party against any other party, and fully and finally terminates this action with prejudice.” (See ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
SWIFT v. PANDEY, Counsel Stack Legal Research, https://law.counselstack.com/opinion/swift-v-pandey-njd-2023.